Prospective Open Labeled Pilot Trial of Quercetin in the Treatment and Prevention of Chemotherapy-induced Neuropathic Pain in Cancer Patients
Withdrawn prior to enrolment
Phase of Trial: Phase 0
Latest Information Update: 24 Apr 2018
At a glance
- Drugs Quercetin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 16 Apr 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 17 Jan 2018 Planned End Date changed from 1 Nov 2019 to 1 Apr 2020.
- 17 Jan 2018 Planned primary completion date changed from 1 Nov 2019 to 1 Apr 2020.